Betacellulin overexpression in transgenic mice improves glucose tolerance and enhances insulin secretion by isolated islets in vitro

Molecular and Cellular Endocrinology

Volumn 299, Issue 2, 2009, Pages 188-193

  Dahlhoff, M ^a   Dames, P M ^b   Lechner, A ^b   Herbach, N ^a   van Burck L ^a   Wanke, R ^a   Wolf, E ^a   Schneider, M R ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Betacellulin; EGFR; Glucose metabolism; Glucose tolerance test; Transgenic mice

Indexed keywords

BETACELLULIN; GLUCOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CELL STRUCTURE; CELL TYPE; CELL VOLUME; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; ENDOCRINE CELL; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELL SEPARATION; GLUCOSE; HOMEOSTASIS; INSULIN; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISLETS OF LANGERHANS; MICE; MICE, TRANSGENIC; TRANSGENES;

EID: 58949095742     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.11.022     Document Type: Article

References (39)

1. Alimandi M., Wang L.M., Bottaro D., Lee C.C., Kuo A., Frankel M., Fedi P., Tang C., Lippman M., and Pierce J.H. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. EMBO J. 16 (1997) 5608-5617
2. Brun T., Franklin I., St. Onge L., Biason-Lauber A., Schoenle E.J., Wollheim C.B., and Gauthier B.R. The diabetes-linked transcription factor PAX4 promotes {beta}-cell proliferation and survival in rat and human islets. J. Cell. Biol. 167 (2004) 1123-1135
3. Buteau J., Foisy S., Joly E., and Prentki M. Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 52 (2003) 124-132
4. Demeterco C., Beattie G.M., Dib S.A., Lopez A.D., and Hayek A. A role for activin A and betacellulin in human fetal pancreatic cell differentiation and growth. J. Clin. Endocrinol. Metab. 85 (2000) 3892-3897
5. Diehl D., Oesterle D., Elmlinger M.W., Hoeflich A., Wolf E., and Lahm H. IGF-II transgenic mice display increased aberrant colon crypt multiplicity and tumor volume after 1,2-dimethylhydrazine treatment. J. Carcinogen. 5 (2006) 24
6. Donath M.Y., and Halban P.A. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications. Diabetologia 47 (2004) 581-589
7. Gundersen H.J. Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. J. Microsc. 111 (1977) 219-223
8. Harris R.C., Chung E., and Coffey R.J. EGF receptor ligands. Exp. Cell Res. 284 (2003) 2-13
9. Herbach N., Goeke B., Schneider M., Hermanns W., Wolf E., and Wanke R. Overexpression of a dominant negative GIP receptor in transgenic mice results in disturbed postnatal pancreatic islet and beta-cell development. Regul. Pept. 125 (2005) 103-117
10. Herbach N., Rathkolb B., Kemter E., Pichl L., Klaften M., de Angelis M.H., Halban P.A., Wolf E., Aigner B., and Wanke R. Dominant-negative effects of a novel mutated Ins2 allele causes early-onset diabetes and severe beta-cell loss in Munich Ins2C95S mutant mice. Diabetes 56 (2007) 1268-1276
11. Huotari M.A., Miettinen P.J., Palgi J., Koivisto T., Ustinov J., Harari D., Yarden Y., and Otonkoski T. ErbB signaling regulates lineage determination of developing pancreatic islet cells in embryonic organ culture. Endocrinology 143 (2002) 4437-4446
12. Huotari M.A., Palgi J., and Otonkoski T. Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel beta-cell mitogen. Endocrinology 139 (1998) 1494-1499
13. Izumi T., Yokota-Hashimoto H., Zhao S., Wang J., Halban P.A., and Takeuchi T. Dominant negative pathogenesis by mutant proinsulin in the Akita diabetic mouse. Diabetes 52 (2003) 409-416
14. Kawaguchi M., Hosotani R., Kogire M., Ida J., Doi R., Koshiba T., Miyamoto Y., Tsuji S., Nakajima S., Kobayashi H., Masui T., and Imamura M. Auto-induction and growth stimulatory effect of betacellulin in human pancreatic cancer cells. Int. J. Oncol. 16 (2000) 37-41
15. Kojima H., Fujimiya M., Matsumura K., Younan P., Imaeda H., Maeda M., and Chan L. NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice. Nat. Med. 9 (2003) 596-603
16. Krakowski M.L., Kritzik M.R., Jones E.M., Krahl T., Lee J., Arnush M., Gu D., Mroczkowski B., and Sarvetnick N. Transgenic expression of epidermal growth factor and keratinocyte growth factor in beta-cells results in substantial morphological changes. J. Endocrinol. 162 (1999) 167-175
17. Li L., Seno M., Yamada H., and Kojima I. Promotion of beta-cell regeneration by betacellulin in ninety percent-pancreatectomized rats. Endocrinology 142 (2001) 5379-5385
18. Li L., Seno M., Yamada H., and Kojima I. Betacellulin improves glucose metabolism by promoting conversion of intraislet precursor cells to beta-cells in streptozotocin-treated mice. Am. J. Physiol. Endocrinol. Metab. 285 (2003) E577-E583
19. Li L., Yi Z., Seno M., and Kojima I. Activin A and betacellulin: effect on regeneration of pancreatic beta-cells in neonatal streptozotocin-treated rats. Diabetes 53 (2004) 608-615
20. Li W.C., Horb M.E., Tosh D., and Slack J.M. In vitro transdifferentiation of hepatoma cells into functional pancreatic cells. Mech. Dev. 122 (2005) 835-847
21. Mashima H., Ohnishi H., Wakabayashi K., Mine T., Miyagawa J., Hanafusa T., Seno M., Yamada H., and Kojima I. Betacellulin and activin A coordinately convert amylase-secreting pancreatic AR42J cells into insulin-secreting cells. J. Clin. Invest. 97 (1996) 1647-1654
22. Means A.L., Ray K.C., Singh A.B., Washington M.K., Whitehead R.H., Harris Jr. R.C., Wright C.V., Coffey Jr. R.J., and Leach S.D. Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia. Gastroenterology 124 (2003) 1020-1036
23. Nielsen J.H., Galsgaard E.D., Moldrup A., Friedrichsen B.N., Billestrup N., Hansen J.A., Lee Y.C., and Carlsson C. Regulation of beta-cell mass by hormones and growth factors. Diabetes 50 Suppl. 1 (2001) S25-S29
24. Niwa H., Yamamura K., and Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108 (1991) 193-199
25. O'Brien B.A., Huang Y., Geng X., Dutz J.P., and Finegood D.T. Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes 51 (2002) 2481-2488
26. Ogata T., Park K.Y., Seno M., and Kojima I. Reversal of streptozotocin-induced hyperglycemia by transplantation of pseudoislets consisting of beta cells derived from ductal cells. Endocr. J. 51 (2004) 381-386
27. Riese D.J., Bermingham Y., van Raaij T.M., Buckley S., Plowman G.D., and Stern D.F. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response patterns distinct from those stimulated by epidermal growth factor or neuregulin-beta. Oncogene 12 (1996) 345-353
28. Sahin U., Weskamp G., Kelly K., Zhou H.M., Higashiyama S., Peschon J., Hartmann D., Saftig P., and Blobel C.P. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands. J. Cell. Biol. 164 (2004) 769-779
29. Schneider M.R., Dahlhoff M., Herbach N., Renner-Mueller I., Dalke C., Puk O., Graw J., Wanke R., and Wolf E. Betacellulin overexpression in transgenic mice causes disproportionate growth, pulmonary hemorrhage syndrome, and complex eye pathology. Endocrinology 146 (2005) 5237-5246
30. Shin S., Li N., Kobayashi N., Yoon J.W., and Jun H.S. Remission of diabetes by beta-cell regeneration in diabetic mice treated with a recombinant adenovirus expressing betacellulin. Mol. Ther. 16 (2008) 854-861
31. Shing Y., Christofori G., Hanahan D., Ono Y., Sasada R., Igarashi K., and Folkman J. Betacellulin: a mitogen from pancreatic beta cell tumors. Science 259 (1993) 1604-1607
32. Sundaresan S., Roberts P.E., King K.L., Sliwkowski M.X., and Mather J.P. Biological response to ErbB ligands in nontransformed cell lines correlates with a specific pattern of receptor expression. Endocrinology 139 (1998) 4756-4764
33. Tada H., Sasada R., Kawaguchi Y., Kojima I., Gullick W.J., Salomon D.S., Igarashi K., Seno M., and Yamada H. Processing and juxtacrine activity of membrane-anchored betacellulin. J. Cell. Biochem. 72 (1999) 423-434
34. Tada H., Seno M., Yamada H., Sasada R., and Igarashi K. Molecular cloning and expression of rat betacellulin cDNA. Biochim. Biophys. Acta 1492 (2000) 285-288
35. Vasavada R.C., Gonzalez-Pertusa J.A., Fujinaka Y., Fiaschi-Taesch N., Cozar-Castellano I., and Garcia-Ocana A. Growth factors and beta cell replication. Int. J. Biochem. Cell Biol. (2005)
36. Wanke R., Weis S., Kluge D., Kahnt D., Schenck E., Brem G., and Herrmanns W. Morphometric evaluation of the pancreas of growth hormone transgenic mice. Acta Stereol. 13 (1994) 3-8
37. Watada H., Kajimoto Y., Miyagawa J., Hanafusa T., Hamaguchi K., Matsuoka T., Yamamoto K., Matsuzawa Y., Kawamori R., and Yamasaki Y. PDX-1 induces insulin and glucokinase gene expressions in alphaTC1 clone 6 cells in the presence of betacellulin. Diabetes 45 (1996) 1826-1831
38. Yamamoto K., Miyagawa J., Waguri M., Sasada R., Igarashi K., Li M., Nammo T., Moriwaki M., Imagawa A., Yamagata K., Nakajima H., Namba M., Tochino Y., Hanafusa T., and Matsuzawa Y. Recombinant human betacellulin promotes the neogenesis of beta-cells and ameliorates glucose intolerance in mice with diabetes induced by selective alloxan perfusion. Diabetes 49 (2000) 2021-2027
39. Yoshida S., Kajimoto Y., Yasuda T., Watada H., Fujitani Y., Kosaka H., Gotow T., Miyatsuka T., Umayahara Y., Yamasaki Y., and Hori M. PDX-1 induces differentiation of intestinal epithelioid IEC-6 into insulin-producing cells. Diabetes 51 (2002) 2505-2513